Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1247589.RAHv-5OjJ-Ox1uvEkEW6yhJtpiUVU_CMn-lkuocuRFcP4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1247589.RAHv-5OjJ-Ox1uvEkEW6yhJtpiUVU_CMn-lkuocuRFcP4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1247589.RAHv-5OjJ-Ox1uvEkEW6yhJtpiUVU_CMn-lkuocuRFcP4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1247589.RAHv-5OjJ-Ox1uvEkEW6yhJtpiUVU_CMn-lkuocuRFcP4130_provenance.
- NP1247589.RAHv-5OjJ-Ox1uvEkEW6yhJtpiUVU_CMn-lkuocuRFcP4130_assertion description "[Besides, the telomerase activity in OVCAR-3 cells was also downregulated after PTP treatment for 48 h. Taken together, the inhibitory effect of PTP on the cell growth was at least in part mediated via the downregulation of Bmi-1 expression and the telomerase activity in OVCAR-3 cells, and PTP might be a new candidate for chemotherapeutic agent against human ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247589.RAHv-5OjJ-Ox1uvEkEW6yhJtpiUVU_CMn-lkuocuRFcP4130_provenance.
- NP1247589.RAHv-5OjJ-Ox1uvEkEW6yhJtpiUVU_CMn-lkuocuRFcP4130_assertion evidence source_evidence_literature NP1247589.RAHv-5OjJ-Ox1uvEkEW6yhJtpiUVU_CMn-lkuocuRFcP4130_provenance.
- NP1247589.RAHv-5OjJ-Ox1uvEkEW6yhJtpiUVU_CMn-lkuocuRFcP4130_assertion SIO_000772 25501509 NP1247589.RAHv-5OjJ-Ox1uvEkEW6yhJtpiUVU_CMn-lkuocuRFcP4130_provenance.
- NP1247589.RAHv-5OjJ-Ox1uvEkEW6yhJtpiUVU_CMn-lkuocuRFcP4130_assertion wasDerivedFrom befree-2016 NP1247589.RAHv-5OjJ-Ox1uvEkEW6yhJtpiUVU_CMn-lkuocuRFcP4130_provenance.
- NP1247589.RAHv-5OjJ-Ox1uvEkEW6yhJtpiUVU_CMn-lkuocuRFcP4130_assertion wasGeneratedBy ECO_0000203 NP1247589.RAHv-5OjJ-Ox1uvEkEW6yhJtpiUVU_CMn-lkuocuRFcP4130_provenance.
- befree-2016 importedOn "2016-02-19" NP1247589.RAHv-5OjJ-Ox1uvEkEW6yhJtpiUVU_CMn-lkuocuRFcP4130_provenance.